Pliant Therapeutics

PLRX50

$12.850.00%$0.00

PLRX50

$12.85

0.00%$0.00

Performance History

Key Stats
Open	$13.70
Prev. Close	$13.77
EPS	-3.35
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	12.81	14.46
52 Week Range	10.22	19.62

Ratios







EPS	-3.35

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc (PLRX) is a biotechnology company focused on the discovery and development of novel therapies for fibrotic diseases. The company's mission is to improve the lives of patients suffering from these debilitating conditions by targeting the underlying biology of fibrosis. Fibrosis is a complex process involving the accumulation of scar tissue in various organs, leading to organ dysfunction and ultimately, organ failure. Pliant Therapeutics is dedicated to addressing this unmet medical need through the development of innovative therapeutics.

One of the key drivers of Pliant Therapeutics' success is its deep understanding of the mechanisms underlying fibrosis. The company's scientific approach is based on years of research and expertise in this field. By targeting specific proteins and signaling pathways involved in fibrosis, Pliant Therapeutics aims to develop highly selective and effective treatments for patients. This targeted approach allows for a more personalized approach to therapy, increasing the chances of success and reducing the potential for adverse effects.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., MBA, Ph.D.
Headquarters: South San Francisco
Employees: 155
Exchange: NASDAQ

Keep an eye on Pliant Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Pliant Therapeutics 's (PLRX) price per share?

The current price per share for Pliant Therapeutics (PLRX) is $12.85. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Pliant Therapeutics (PLRX)?

For Pliant Therapeutics (PLRX), the 52-week high is $19.62, which is 52.68% from the current price. The 52-week low is $10.22, the current price is 25.73% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Pliant Therapeutics (PLRX) a growth stock?

Pliant Therapeutics (PLRX) has shown an average price growth of -3.55% over the past three years. It has received a score of 44 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pliant Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Pliant Therapeutics (PLRX) stock price performance year to date (YTD)?

As of the latest data, Pliant Therapeutics (PLRX) has a year-to-date price change of -28.45%. Over the past month, the stock has experienced a price change of -6.41%. Over the last three months, the change has been 7.71%. Over the past six months, the figure is -9.12%.

help

Is Pliant Therapeutics (PLRX) a profitable company?

Pliant Therapeutics (PLRX) has a net income of -$161.34M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.58M, although specific revenue growth data is currently not available. Operating income is noted at -$184.14M. Furthermore, the EBITDA is -$219.95M.

help

What is the market capitalization of Pliant Therapeutics (PLRX)?

Pliant Therapeutics (PLRX) has a market capitalization of $781.97M. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.